Display options
Cite
Lerche S, Heinzel S, Alves GW, et al. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016;8:121doi: 10.3389/fnagi.2016.00121.
Lerche, S., Heinzel, S., Alves, G. W., Barone, P., Behnke, S., Ben-Shlomo, Y., Berendse, H., Bloem, B. R., Burn, D., Dodel, R., Grosset, D. G., Hipp, G., Hu, M. T., Kasten, M., Krüger, R., Liepelt-Scarfone, I., Maetzler, W., Moccia, M., Mollenhauer, B., Oertel, W., Roeben, B., Walter, U., Wirdefeldt, K., & Berg, D. (2016). Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Frontiers in aging neuroscience, 8121. https://doi.org/10.3389/fnagi.2016.00121
Lerche, Stefanie, et al. "Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies." Frontiers in aging neuroscience vol. 8 (2016): 121. doi: https://doi.org/10.3389/fnagi.2016.00121
Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016. PMID: 27303289; PMCID: PMC4882324.
Copy Download .nbib Format: NLM
Share it on

Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016.

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Frontiers in aging neuroscience

Stefanie Lerche, Sebastian Heinzel, Guido W Alves, Paolo Barone, Stefanie Behnke, Yoav Ben-Shlomo, Henk Berendse, Bastiaan R Bloem, David Burn, Richard Dodel, Donald G Grosset, Geraldine Hipp, Michele T Hu, Meike Kasten, Rejko Krüger, Inga Liepelt-Scarfone, Walter Maetzler, Marcello Moccia, Brit Mollenhauer, Wolfgang Oertel, Benjamin Roeben, Uwe Walter, Karin Wirdefeldt, Daniela Berg

Affiliations

  1. Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany.
  2. Norwegian Centre for Movement Disorders, Stavanger University Hospital Stavanger, Norway.
  3. Neuroscience Section, Center for Neurodegenerative Diseases (CEMAND), Department of Medicine and Surgery, University of Salerno Salerno, Italy.
  4. Department of Neurology, Saarland University Hospital Homburg, Germany.
  5. School of Social and Community Medicine, University of Bristol Bristol, UK.
  6. Department of Neurology and Neuroscience Campus Amsterdam, VU University Hospital Amsterdam, Netherlands.
  7. Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior Nijmegen, Netherlands.
  8. Institute of Neuroscience, Newcastle University Newcastle, UK.
  9. Department of Neurology, Philipps-Universität Marburg Marburg, Germany.
  10. Institute of Neurological Sciences, Queen Elizabeth University Hospital Glasgow, UK.
  11. Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine, University of LuxembourgBelval, Luxembourg; Centre Hospitalier LuxembourgLuxembourg, Luxembourg.
  12. Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford Oxford, UK.
  13. Institute of Neurogenetics, University of Lübeck Lübeck, Germany.
  14. Paracelsus-Elena-KlinikKassel, Germany; University Medical Center, Georg-August-Universität GöttingenGöttingen, Germany.
  15. Department of Neurology, University of Rostock Rostock, Germany.
  16. Department of Epidemiology and Biostatistics, Karolinska InstitutetStockholm, Sweden; Department of Clinical Neuroscience, Karolinska InstitutetStockholm, Sweden.
  17. Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany; Department of Neurology, Christian-Albrechts UniversityKiel, Germany.

PMID: 27303289 PMCID: PMC4882324 DOI: 10.3389/fnagi.2016.00121

[No abstract available.]

Keywords: Parkinson's disease; cohort studies; harmonization; marker

References

  1. Mov Disord. 2015 Mar;30(3):402-6 - PubMed
  2. Mov Disord. 2016 Apr;31(4):593-6 - PubMed
  3. Neurology. 2010 Sep 21;75(12):1062-9 - PubMed
  4. Neuroepidemiology. 2015 ;45(4):282-97 - PubMed
  5. Mov Disord. 2012 Mar;27(3):349-56 - PubMed
  6. J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1008-13 - PubMed

Publication Types